Most Schistosoma mansoni infections are egg-negative after a single dose of oxamniquine. A cohort of 661 infected children was treated at 6-month intervals and assessed for nutritional and parasitological status. Initial biochemical and immunologic markers were measured in a subset of 84 children. All were treated at the start of therapy and at 6 months. Immunoglobulins only served as markers for active infection. No markers were predictive of cure or reinfection, except initial infection intensity and serum low-density lipoprotein. Ten percent were persistently infected and had no change in infection intensity at any time-point. Several factors suggest that this group was biologically different. In addition to failing to reduce their worm burden, they had significantly higher initial intensity of infection (100 versus 65 eggs/g, P = 0.001) and significantly lower initial serum low-density lipoprotein (72 versus 104 mg/dL, P = 0.045). The biologic plausibility of this observation is discussed. Copyright © 2006 by The American Society of Tropical Medicine and Hygiene.
CITATION STYLE
Reis, E. A. G., Reis, M. G., Silva, R. D. C. R., Carmo, T. M. A., Assis, A. M. O., Barreto, M. L., … Blanton, R. E. (2006). Biochemical and immunologic predictors of efficacy of treatment or reinfection risk for Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 75(5), 904–909. https://doi.org/10.4269/ajtmh.2006.75.904
Mendeley helps you to discover research relevant for your work.